$1.6M EBITDA, Full Service Dental Laboratory

XYDT1M - $1.6 Million EBITDA, Highly Profitable and Scalable Full Service Dental Laboratory Located on the Upper East Coast

Company Overview
Broker is pleased to exclusively represent a well-established, 40 year old, highly profitable Dental Laboratory located on the east coast of United States. This dental lab has been in business for almost 4 decades and serves both smaller dental practices as well large dental groups (DSO’s) on the east coast. The Company serves smaller solo-dentist practices and large dental groups (DSO’s) with the largest customer base in New Jersey, followed by Pennsylvania and New York.

This dental lab has leveraged both in-house and offshore manufacturing for the past 40 years to attain extremely healthy profit margins (much higher than average U.S. dental labs), and a very strong balance sheet. The Company continues to show stellar growth with the introduction of 3-D printers and milling. They began investing in digital scanners, 3D printers, and milling machines to increase operational efficiencies, and they currently have 3 digital scanners and two 3-D printers.

Financial Overview
Historically, the company has always been highly profitable with very strong financial performance and balance sheet. The company has no debt. It has been investing in digital workflow and technologies, and it has developed its own unique tool to reduce the time and cost of fabricating implant-related prostheses while enjoying spectacular profits. The company is on track to achieve a revenue of nearly $5 million in 2025 with an adjusted EBITDA of $1.6 million.

Transition Plan
The owner is at retirement age and is looking for a transition of his legacy. He is open to staying on and retaining up to 20% equity with a qualified buyer.

Asking Price
The asking price for this investment opportunity is $11 million. The price excludes working capital inventory, any cash, and accounts receivable and real estate. The Seller is open to remaining in business and retain up to 20% equity with a suitable buyer experiences in scaling companies.